Skin Testing in Fixed Drug Eruptions: A Useful and Safe Tool?
The Journal of Allergy and Clinical Immunology: In Practice · 2024-02 · 12 (2) · 469-471
DOI: 10.1016/j.jaip.2023.11.033 ↗Kurz gefasst
Editorial in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024-02. Verfasst von Joseph Jayasundera und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine & Allergy, Homerton Healthcare NHS Foundation Trust, London, United Kingdom. Hauptthemen laut MEDLINE: Drug Eruptions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Respiratory Medicine & Allergy, Homerton Healthcare NHS Foundation Trust, London, United Kingdom.
- Department of Respiratory Medicine & Allergy, Homerton Healthcare NHS Foundation Trust, London, United Kingdom; National Heart & Lung Institute, Imperial College London, London, United Kingdom. Electronic address: t.wat…
Zitieren
APA
Jayasundera, J., & Watts, T. J. (2024). Skin Testing in Fixed Drug Eruptions: A Useful and Safe Tool?. The Journal of Allergy and Clinical Immunology: In Practice, 12(2), 469-471. https://doi.org/10.1016/j.jaip.2023.11.033
Vancouver
Jayasundera J, Watts TJ. Skin Testing in Fixed Drug Eruptions: A Useful and Safe Tool?. The Journal of Allergy and Clinical Immunology: In Practice. 2024;12(2):469-471. doi:10.1016/j.jaip.2023.11.033
BibTeX
@article{Jayasundera2024,
author = {Jayasundera, Joseph and Watts, Timothy J},
title = {Skin Testing in Fixed Drug Eruptions: A Useful and Safe Tool?},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2024},
volume = {12},
number = {2},
pages = {469--471},
doi = {10.1016/j.jaip.2023.11.033}
}
EUVIMED